Michelle Greene

Michelle graduated with a degree in Pharmacy from Queen’s University Belfast (QUB) in 2010 and subsequently completed a pre-registration training year in the primary healthcare setting. She returned to QUB in 2011 to undertake a PhD in nanomedicine, focusing on the development of an immunomodulatory nanoparticle for the treatment of Acute Respiratory Distress Syndrome. This technology has since been outlicensed and has now progressed to Phase IIb/III clinical testing. Following her PhD, Michelle took up a postdoctoral position at QUB, initially within the School of Pharmacy before later transitioning to the Patrick G Johnston Centre for Cancer Research, where she primarily worked on the application of nanotechnology for improved tumour therapy. She was recently appointed as a Senior Research Fellow at the newly established Future Medicines Institute at QUB; a £55M collaborative hub for cutting-edge research and innovation amongst industry, academia and healthcare professionals. Here, she plays a leading role in driving forward the Institute’s vision to strengthen the R&D productivity and global standing of the Northern Ireland Life & Health Sciences sector in precision medicine and diagnostics.